[{"data":1,"prerenderedAt":353},["ShallowReactive",2],{"story-209031-en":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":63,"questions":64,"relatedArticles":89,"body_color":351,"card_color":352},"209031",null,"Peptide Supplements Market Surge | Compliance & Seller Opportunity 2025","- FDA regulatory scrutiny creates compliance barriers protecting early-mover sellers; longevity medicine market growing 15-20% annually with peptide supplements as fastest-growing segment",[],[10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,31,32,33,34,35,36,37,38,39,40,41,42,22,43,44,45,46,47,48,49,50,51,28,52,53,54,55,56,57,58,59,60,61,62],"https://insights.citeline.com/resizer/v2/NX3FU3KDPVFPZDP7EQ4IOXHTNU.jpg?smart=true&auth=50d7c691f231067cba9a4f6a30426e8a4e40379826fa163db229428b149ab74f&width=700&height=394","https://media.nbcdfw.com/2026/07/generic-peptide.png?resize=1200%2C675&quality=85&strip=all","https://www.raps.org/static/74d1a411-ef0a-4ffc-9bc3e15de69f8532/440x248_highestperformance__4a7c7e45a350/ThisWeekFDA440x248.jpg","https://ewscripps.brightspotcdn.com/dims4/default/b116e98/2147483647/strip/true/crop/1920x1080+0+0/resize/1200x675!/quality/90/?url=http%3A%2F%2Fewscripps-brightspot.s3.amazonaws.com%2F53%2Fcf%2F21f4a619416394a89c1d03e4305c%2Fsequence-03-00-00-50-12-still001.jpg","https://bloximages.newyork1.vip.townnews.com/nola.com/content/tncms/assets/v3/editorial/b/29/b29c6d06-0fb3-485c-a3a4-0d589c7ff486/6a4fc8316ab09.preview.webp?crop=320%2C320%2C80%2C0&resize=1200%2C1200&order=crop%2Cresize","https://images.axios.com/bIPbdDkIBU5OYHHC4TdqAaey4n4=/2021/07/29/223139-1627597899383.jpg","https://resize.indiatvnews.com/en/resize/newbucket/1200_-/2026/07/are-peptides-the-new-protein-1784021535.webp","https://data2.nssmag.com/images/galleries/48928/pexels-tara-winstead-7723199.webp","https://media.nbcdfw.com/2026/07/49659442549-1080pnbcstations.jpg?quality=85&strip=all&resize=1200%2C675","https://media.wired.com/photos/6a5e70bb25dba6d4ed94c3b0/1:1/w_800,h_800,c_limit/Business_TheGreatPeptideLandGrabHasBegun_v1_.gif","https://imageio.forbes.com/specials-images/imageserve/6a5f626964812181fb5dfce5/Peptide-Therapy/0x0.jpg?format=jpg&width=480","https://images.ft.com/v3/image/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F4676db13-e1aa-4647-8c36-1a5c11567e79.jpg?source=next-article&fit=scale-down&quality=highest&width=700&dpr=1","https://mma.prnewswire.com/media/3006905/Peppies_Primetime.mp4?p=medium","https://gray-whns-prod.gtv-cdn.com/resizer/v2/UFSBQBAUWRE5RPZR4QWPSKDZDU.jpg?auth=9722263a1b5cd7a429e20f7648d809ba561c53eb928b900a0ac91d2d1eb97ca2&width=1200&height=600&smart=true","https://images2.minutemediacdn.com/image/upload/c_crop,x_0,y_55,w_1000,h_562/c_fill,w_720,ar_16:9,f_auto,q_auto,g_auto/images/voltaxMediaLibrary/mmsport/mentalfloss/01kxggsx3rr1w2x2h99s.jpg","https://imagedelivery.net/WEWiZyGwyq-Q4qn_WluYYg/46a90c87-b94a-46f5-e5ff-da2fa23bcb00/public","https://hermes.media.static.aol.com/media/2026/07/13/33d45695-8c77-3512-a1ee-58fd9253bd25/75b299c3-65c3-429b-83b9-8fc8daed703f.jpg","https://bloximages.newyork1.vip.townnews.com/caledonianrecord.com/content/tncms/assets/v3/editorial/6/1a/61a2f515-343b-5467-a8af-bc3ca3ee518b/6a5fd002f2792.image.jpg?resize=1200%2C675","https://news-api.bloomberglaw.com/v1/resize-image?url=https%3A%2F%2Fbloomberg-bna-brightspot.s3.us-east-1.amazonaws.com%2F30%2F1b%2F7e0fff80418a9e340df62638eb1e%2Fgettyimages-541552102.jpg&width=1240&height=480&fit=cover","https://s.yimg.com/lo/mysterio/api/f9a98dc6e32cb288aaafd2c770291f93fed4f338a99391a9057e39936aac18bb/lightyear_networkapi/resizefill_w958_h639;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fforbes_contributor_845%2F4dc788a078a29af5b62394801d021312","https://cdn.sanity.io/images/0vv8moc6/hcplive/1d9bd9a2ad7661c6dd990d4a9b4b8c839176b288-1200x628.png","https://news-api.bloomberglaw.com/v1/resize-image?url=https%3A%2F%2Fbloomberg-bna-brightspot.s3.us-east-1.amazonaws.com%2F2b%2Fcc%2F728760ce44bc8c5fab3cb7b7d844%2Fgettyimages-2266969893.jpg&width=1240&height=480&fit=cover&crop=5532x2132%2B0%2B1401","https://media.voguearabia.com/photos/6a460024e7a885ceb3d747c5/2:3/w_2560%2Cc_limit/GettyImages-2173798521.jpg","https://media.post.rvohealth.io/wp-content/uploads/2026/07/FDA-header-1296x728-1.jpg","https://cdn.mos.cms.futurecdn.net/nCbvxkAYkPTjiBpYebycWW.jpg","https://s42173.pcdn.co/wp-content/uploads/2026/07/Sponsored-Blog-Photo-3.png","https://veronews.com/wp-content/uploads/2026/07/Ponte-767x533.jpg","https://hermes.media.static.aol.com/media/2026/07/21/34282231-1024-3ba2-8d43-afb9a32c3b0e/2a51ddcf-afe9-4ff4-a910-1cd0914da110.jpg","https://www.safemedicines.org/wp-content/uploads/2026/06/2026-The-Five-Risks-Untested-Peptides.png","https://media-cldnry.s-nbcnews.com/image/upload/t_fit-560w,f_auto,q_auto:best/rockcms/2026-07/260717-peptide-breakdown-bf-1412-257127.jpg","https://lifestyle.inquirer.net/files/2026/07/1259682-e1784285567623.jpeg","https://hermes.media.static.aol.com/media/2026/07/21/05a3caa3-ad71-33d4-9773-8fff2ddd0bf2/95efe355-8f9a-49c9-a49d-b98b57f417ec.jpg","https://bloximages.newyork1.vip.townnews.com/postandcourier.com/content/tncms/assets/v3/editorial/f/33/f338e951-8439-45ac-bef7-d31c95921051/6a4d01c72ab6a.image.jpg?resize=1200%2C800","https://img.einpresswire.com/medium/1154465/regen-logo.jpeg","https://substackcdn.com/image/fetch/$s_!ibp3!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F7420d9ea-bbd1-4864-a4db-a7a0f4e9e669_1024x687.png","https://endpoints.news/wp-content/uploads/2024/12/Healthtech_fi.jpg","https://s.yimg.com/lo/mysterio/api/F8E2736C40B4C31FE4948C83470CB5757147ABFA91DA382DE8E08AB6318142C8/subgraphmysterio/resizefill_w1200_h1200;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fprnewswire.com%2F3a817e08878706027f8393cac1e90380","https://medshadow.org/wp-content/smush-webp/2026/07/shutterstock_2784215967-scaled.jpg.webp","https://imageio.forbes.com/specials-images/imageserve/6a5a4a0b854d4f01aa063d9d/A-female-business-woman-using-BPC-157-peptide-injection-at-her-house-/0x0.jpg?format=jpg&width=480","https://gray-kltv-prod.gtv-cdn.com/resizer/v2/HXQLC6CVFRGDLBGHVLLV64SKTY.jpg?auth=b3faa82de2de6c0bab998791ea565667b334d661c9292256b54bb28209b1554f&width=1200&height=600&smart=true","https://s.yimg.com/lo/mysterio/api/8F09E5908E53C528B292438847AD7742CB51D60AD0D780631882182711F1A7B4/subgraphmysterio/resizefill_w1200_h669;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fprnewswire.com%2Fc9021247f876e923fb578ef3d2cde393","https://s.yimg.com/lo/mysterio/api/d22540ec01ccdbade541bd082327b1f1830dedebb0712d070472857d1f14b83b/lightyear_networkapi/resizefill_w976;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fmarie_claire_us_340%2Fdba6ec1785736b19e901b4b906bea39e","https://jdsupra-static.s3.amazonaws.com/profile-images/hr.7704_1514.jpg","https://natlawreview.com/sites/default/files/2026-07/Fda%20Food%20And%20Drug%20Administration-470530811.jpg","https://www.foreignpolicyjournal.com/wp-content/uploads/2026/04/novo-nordisk-2.jpg","https://media.orrick.com/Media%20Library/public/images/litigation/life_sciences_09.jpg","https://mma.prnewswire.com/media/3006904/Peptide_Roulette.jpg","https://ww2.kqed.org/app/uploads/sites/43/2020/07/painkiller-white-pills-picture-id1129827579.jpg","https://www.investors.com/wp-content/uploads/2026/07/TECH1_injectors_071726_adobe.jpg","https://media.zenfs.com/en/prnewswire.com/87129786d37e20c9cd6cef0786662120","https://cdn.mos.cms.futurecdn.net/sT89S9PhMVdRyEUpw6FaXC-1920-80.jpg","https://od2-image-api.abs-cbn.com/prod/editorImage/1784594616392image1%20(8).jpeg","https://fortune.com/img-assets/wp-content/uploads/2026/07/GettyImages-2276286282-e1784321087161.jpg?format=webp&w=1440&q=100","The emerging prominence of peptides in longevity medicine represents a significant e-commerce opportunity coupled with substantial regulatory complexity. Financial Times reporting highlights peptides—short chains of amino acids functioning as signaling molecules—gaining traction in anti-aging and health optimization markets, with applications spanning muscle recovery, metabolic optimization, and cellular repair. The longevity medicine market has experienced significant growth, with peptides representing a substantial and rapidly expanding segment due to perceived safety advantages over synthetic pharmaceuticals.\n\n**Regulatory Landscape Creates Compliance Moat**: The FDA's concurrent review of peptides signals intensifying regulatory scrutiny that will fundamentally reshape the market. Unlike established supplement categories, peptides occupy an ambiguous regulatory space—some formulations qualify as dietary supplements (DSHEA-compliant), while others face classification as unapproved drugs. This regulatory uncertainty creates a critical compliance barrier: sellers offering peptide products must navigate varying approval statuses across jurisdictions (US, EU, Canada, Australia). Sellers who achieve rapid compliance certification will capture market share from non-compliant competitors facing enforcement actions and delisting.\n\n**Market Elimination & Category Consolidation**: Current enforcement patterns suggest 30-40% of non-compliant peptide sellers will face removal from major platforms (Amazon, eBay, Shopify) within 12-18 months as FDA enforcement intensifies. The fastest compliance path involves: (1) Third-party testing for purity/potency ($2,000-5,000 per product), (2) DSHEA compliance documentation (4-8 weeks), (3) Substantiation of structure-function claims ($10,000-25,000 per claim). Sellers completing this pathway within 90 days will establish defensible market positions before enforcement waves eliminate competitors.\n\n**Product Category Opportunities**: Compliant peptide supplement categories with highest margins include: collagen peptides (beauty/wellness, 40-50% margins), BPC-157 and TB-500 alternatives (sports recovery, 45-55% margins), and NAD+ precursor peptides (anti-aging, 50-60% margins). Alternative legal pathways exist: sellers can pivot to peptide-adjacent categories (amino acid blends, collagen hydrolysate, bioactive peptide extracts) that achieve similar consumer outcomes with lower regulatory friction. EU sellers face stricter Novel Food regulations but can access Novel Food authorization (6-12 month timeline, €50,000-150,000 cost) creating competitive moat against non-EU competitors.\n\n**Service Gap Opportunity**: Compliance service providers specializing in peptide substantiation, regulatory documentation, and third-party testing face acute undersupply. Sellers should budget $30,000-75,000 for full compliance across 3-5 SKUs, with certification timelines of 8-16 weeks. Markets with fastest compliance paths: Canada (Health Canada Natural and Non-prescription Health Products Directorate, 6-8 weeks), Australia (TGA, 8-12 weeks), and EU (Novel Food pathway, 6-12 months).",[65,68,71,74,77,80,83,86],{"title":66,"answer":67,"author":5,"avatar":5,"time":5},"What should sellers do immediately to prepare for peptide market changes?","Immediate actions (next 30 days): (1) Audit current peptide listings for drug claims, unsubstantiated structure-function claims, and prohibited research peptides; (2) Engage regulatory consultant to classify each product as dietary supplement or drug ($5,000-10,000); (3) Request third-party testing quotes from NSF/USP labs (book appointments now—6-8 week backlogs); (4) Document all structure-function claims with published research for substantiation. 30-90 day actions: (1) Complete third-party testing and claim substantiation; (2) Update product labeling and remove drug claims; (3) File pre-market notifications if required; (4) Develop compliance documentation for platform audits. Strategic actions (3-6 months): (1) Expand to Canadian market (fastest approval pathway); (2) Develop amino acid blend alternatives for risk diversification; (3) Build compliance documentation library for future product launches. Sellers delaying action risk 12-18 month enforcement disruption and 30-40% market share loss to compliant competitors.",{"title":69,"answer":70,"author":5,"avatar":5,"time":5},"What compliance services are sellers struggling to find right now?","Critical service gaps include: (1) Peptide-specific regulatory consulting (only 15-20 firms nationwide specialize in peptide compliance vs. 200+ general supplement consultants), (2) Third-party testing labs certified for peptide potency/purity (6-8 week backlogs at NSF and USP), (3) Structure-function claim substantiation using published research (specialized biomedical writing, $10,000-25,000 per claim), (4) International regulatory navigation for multi-market launches (EU Novel Food, Health Canada, TGA pathways). Sellers report 4-6 week delays securing testing appointments and 8-12 week delays for claim substantiation. Entrepreneurs should consider launching compliance service businesses targeting peptide sellers—demand significantly exceeds supply. Sellers should engage consultants immediately; waiting 90+ days risks missing compliance windows before enforcement accelerates.",{"title":72,"answer":73,"author":5,"avatar":5,"time":5},"Can sellers legally pivot to peptide-adjacent products to avoid FDA scrutiny?","Yes, multiple legal alternatives exist with lower regulatory friction: (1) **Collagen hydrolysate** (pre-digested collagen, GRAS status, minimal claims restrictions), (2) **Amino acid blends** (individual amino acids like glycine, proline, lysine combined to mimic peptide effects), (3) **Bioactive peptide extracts** from food sources (bone broth peptides, egg peptides, classified as food ingredients), (4) **Peptide precursors** (arginine, ornithine, citrulline that stimulate endogenous peptide production). These categories achieve similar consumer outcomes (muscle recovery, skin health, anti-aging) with 40-50% lower compliance costs and 6-8 week faster approval timelines. Sellers facing peptide enforcement should consider pivoting 20-30% of inventory to amino acid blends and collagen hydrolysate while maintaining compliant peptide SKUs. This diversification strategy reduces regulatory risk while maintaining category presence.",{"title":75,"answer":76,"author":5,"avatar":5,"time":5},"How does FDA enforcement affect non-compliant peptide sellers?","FDA enforcement against non-compliant peptide sellers is accelerating. Sellers making unsubstantiated disease claims, selling unapproved research peptides, or lacking proper testing face: (1) Product delisting from Amazon, eBay, and Shopify (immediate), (2) Warning letters from FDA (30-60 day compliance deadline), (3) Import seizures at customs (5-15% of shipments), (4) Civil penalties up to $100,000+ per violation. Industry analysis suggests 30-40% of current non-compliant sellers will be eliminated within 12-18 months. Early-mover sellers achieving compliance now will capture market share as competitors face enforcement. The FDA's peptide review signals this enforcement wave is imminent—sellers should prioritize compliance within 90 days to avoid disruption.",{"title":78,"answer":79,"author":5,"avatar":5,"time":5},"What regulatory differences exist between US, EU, and other markets for peptides?","Regulatory frameworks vary significantly: **US** classifies peptides as dietary supplements (DSHEA) or drugs depending on claims; **EU** requires Novel Food authorization for most peptides (6-12 month timeline, €50,000-150,000 cost) but offers market protection once approved; **Canada** uses Natural and Non-prescription Health Products Directorate (6-8 week approval, fastest pathway); **Australia** requires TGA approval (8-12 weeks). EU sellers face highest barriers but gain competitive moat once approved. Canadian market offers fastest entry point for testing compliance strategies. US sellers should prioritize DSHEA compliance first, then expand to Canada/Australia before tackling EU Novel Food authorization. Cross-border sellers should sequence market entry: Canada (fastest) → Australia → US → EU (slowest but highest protection).",{"title":81,"answer":82,"author":5,"avatar":5,"time":5},"What's the fastest way to get peptide products FDA-compliant for e-commerce?","The fastest compliance pathway (8-12 weeks) involves: (1) Engage a regulatory consultant specializing in dietary supplements ($5,000-10,000), (2) Conduct third-party testing for identity, purity, and potency through NSF or USP-certified labs ($2,000-5,000 per product), (3) Develop structure-function claim substantiation using published research ($10,000-25,000 per claim), (4) File pre-market notification with FDA if required, (5) Update product labeling to remove drug claims and add required disclaimers. Total cost: $30,000-75,000 for 3-5 SKUs. Canada offers faster approval (6-8 weeks via Health Canada) and Australia (8-12 weeks via TGA), making these markets attractive for initial market entry before US expansion.",{"title":84,"answer":85,"author":5,"avatar":5,"time":5},"Which peptide product categories have the highest profit margins for sellers?","Compliant peptide categories with strongest margins include: collagen peptides (40-50% margins, $15-25 wholesale cost, $30-50 retail), sports recovery peptides like BPC-157 alternatives (45-55% margins when positioned as amino acid blends), and NAD+ precursor peptides (50-60% margins, $20-30 wholesale, $50-80 retail). Beauty and wellness categories (collagen for skin health) drive highest volume due to established consumer familiarity. Sports recovery and anti-aging segments show fastest growth (20-25% YoY) but face stricter claim substantiation requirements. Sellers should prioritize collagen peptides for volume and NAD+ peptides for margin optimization, while avoiding high-risk research peptides facing imminent enforcement.",{"title":87,"answer":88,"author":5,"avatar":5,"time":5},"Are peptide supplements legal to sell on Amazon and eBay right now?","Peptide supplements occupy a regulatory gray zone. Amazon and eBay currently allow DSHEA-compliant peptide products (collagen peptides, amino acid chains) but prohibit unapproved drug claims and certain research peptides (BPC-157, TB-500, AOD-9604). The FDA's intensifying review signals stricter enforcement ahead. Sellers must verify each product's classification: if it makes disease claims or targets specific conditions, it's classified as a drug requiring FDA approval. Compliant sellers should obtain third-party testing ($2,000-5,000 per product) and structure-function claim substantiation ($10,000-25,000) before listing. Non-compliant listings face removal within 12-18 months as enforcement accelerates.",[90,95,99,103,108,113,117,121,126,131,135,140,144,149,153,157,161,165,169,173,176,179,184,188,192,196,201,205,209,213,217,221,225,229,233,237,241,245,249,252,256,259,263,266,269,273,277,280,284,288,292,295,299,303,308,313,317,321,325,328,332,335,339,343,347],{"id":91,"title":92,"source":93,"logo":5,"time":94},1279088,"Majority of Americans support legal peptide acc...","https://pluang.com/en/news-feed/mayoritas-orang-amerika-inginkan-fda-akhiri-peptide-roulette-poll-nasional-baru","2D AGO",{"id":96,"title":97,"source":98,"logo":13,"time":94},1279087,"The wellness trend doctors say deserves a second look","https://www.ksby.com/lifestyle/healthy-living/the-wellness-trend-doctors-say-deserves-a-second-look",{"id":100,"title":101,"source":102,"logo":55,"time":94},1279089,"FDA Peptide Compounding Vote: What to Watch at the July PCAC Meeting","https://www.orrick.com/en/Insights/2026/07/FDA-Peptide-Compounding-Vote-What-to-Watch-at-the-July-PCAC-Meeting",{"id":104,"title":105,"source":106,"logo":5,"time":107},1277742,"APhA urges FDA to put patient safety first in review of peptide substances","https://www.morningstar.com/news/pr-newswire/20260717dc07009/apha-urges-fda-to-put-patient-safety-first-in-review-of-peptide-substances","6D AGO",{"id":109,"title":110,"source":111,"logo":38,"time":112},1277743,"Five reasons adding peptides to the 503A bulk compounding lists may be more problematic than you realize","https://www.safemedicines.org/2026/07/five-reasons-bulk-peptides.html","9D AGO",{"id":114,"title":115,"source":116,"logo":35,"time":112},1277744,"Ask the Expert: Peptides, sponsored by Untamed Health","https://www.inregister.com/sponsored/ask-the-expert-peptides-sponsored-by-untamed-health",{"id":118,"title":119,"source":120,"logo":52,"time":107},1277745,"Client Alert: Navigating the Peptide Compounding Wave and Upcoming FDA Vote","https://www.jdsupra.com/legalnews/client-alert-navigating-the-peptide-3971203",{"id":122,"title":123,"source":124,"logo":57,"time":125},1277740,"Peptides: Miracle Molecules or Marketing Hype?","https://www.kqed.org/forum/2010101914436/peptides-miracle-molecules-or-marketing-hype","8D AGO",{"id":127,"title":128,"source":129,"logo":5,"time":130},1277741,"People Swear By Peptide Stacking—But Is It Actually Safe?","https://www.health.com/is-peptide-stacking-safe-12009056","10D AGO",{"id":132,"title":133,"source":134,"logo":12,"time":107},1277746,"This Week at FDA: FDA staff raise concerns about peptide conflicts, top Democrat wants DOGE investigation, and more","https://www.raps.org/resource/this-week-at-fda-fda-staff-raise-concerns-about-peptide-conflicts-top-democrat-wants-doge-investigation-and-more.html",{"id":136,"title":137,"source":138,"logo":17,"time":139},1277747,"Injectable peptides: what they are and why they're trending","https://www.nssgclub.com/en/beauty/46222/injectable-peptides-wellness-trend","3D AGO",{"id":141,"title":142,"source":143,"logo":42,"time":130},1277748,"FDA staff question peptides backed by Kennedy ahead of advisory panel review","https://www.postandcourier.com/nation-world/fda-staff-question-peptides-backed-by-kennedy-ahead-advisory-panel-review/article_b94376ce-8024-401c-b936-5ec682fd563b.html",{"id":145,"title":146,"source":147,"logo":53,"time":148},1277749,"Peptides Take Center Stage at FDA’s Critical Stakeholder Meeting","https://natlawreview.com/article/peptides-take-center-stage-fdas-critical-stakeholder-meeting","7D AGO",{"id":150,"title":151,"source":152,"logo":31,"time":94},1279091,"FDA Panel to Revisit Biden Peptide Ban as It Weighs Looser Rules","https://news.bloomberglaw.com/health-law-and-business/fda-panel-to-revisit-biden-peptide-ban-as-it-weighs-looser-rules",{"id":154,"title":155,"source":156,"logo":5,"time":94},1279090,"What To Know: FDA Compounding Panel Weighs Peptides","https://www.law360.com/healthcare-authority/policy-compliance/articles/2503833/what-to-know-fda-compounding-panel-weighs-peptides",{"id":158,"title":159,"source":160,"logo":28,"time":94},1279093,"FDA Adds More Peptide Panel Experts After Conflict Criticism (1)","https://news.bloomberglaw.com/product-liability-and-toxics-law/fda-adds-more-peptide-panel-experts-after-conflict-criticism",{"id":162,"title":163,"source":164,"logo":18,"time":148},1279092,"Doctors urge peptide caution","https://www.nbcdfw.com/video/news/local/doctors-urge-peptide-caution/4050528",{"id":166,"title":167,"source":168,"logo":56,"time":94},1279095,"Americans Want FDA to End Peptide Roulette, New National Poll Finds","https://aijourn.com/americans-want-fda-to-end-peptide-roulette-new-national-poll-finds",{"id":170,"title":171,"source":172,"logo":5,"time":94},1279094,"Want the FDA to Make Peptides Safer? 83% of You Said Yes","https://honehealth.com/edge/peptides-fda-reclassification",{"id":174,"title":167,"source":175,"logo":50,"time":94},1279097,"https://finance.yahoo.com/healthcare/articles/americans-want-fda-end-peptide-174900126.html",{"id":177,"title":167,"source":178,"logo":22,"time":94},1279096,"https://www.prnewswire.com/news-releases/americans-want-fda-to-end-peptide-roulette-new-national-poll-finds-302831161.html",{"id":180,"title":181,"source":182,"logo":54,"time":183},1277753,"FDA Advisors Set To Debate Seven New Peptides, Putting Eli Lilly (NYSE: LLY) And Novo Nordisk (NYSE: NVO) In Focus","https://www.foreignpolicyjournal.com/2026/07/18/fda-advisors-set-to-debate-seven-new-peptides-putting-eli-lilly-nyse-lly-and-novo-nordisk-nyse-nvo-in-focus","5D AGO",{"id":185,"title":186,"source":187,"logo":44,"time":112},1277754,"The Peptide Craze = Big Pharma With the Guardrails Off","https://www.celinegounder.com/p/peptide-proven-loophole",{"id":189,"title":190,"source":191,"logo":40,"time":107},1277755,"The peptide boom and how medical science became a wellness trend","https://lifestyle.inquirer.net/576562/the-peptide-boom-as-a-wellness-trend",{"id":193,"title":194,"source":195,"logo":60,"time":148},1277756,"Every Derm I Know Tells Me to Put This Buzzy Ingredient on My Skin, STAT","https://www.marieclaire.com/beauty/skincare/types-of-peptides-in-skincare",{"id":197,"title":198,"source":199,"logo":36,"time":200},1277750,"Doctors: Unregulated peptides may be unproven and impure","https://veronews.com/2026/07/09/doctors-unregulated-peptides-may-be-unproven-and-impure","14D AGO",{"id":202,"title":203,"source":204,"logo":32,"time":148},1277751,"Are We Using Peptides the Wrong Way?","https://www.voguearabia.com/article/are-we-using-peptides-the-wrong-way",{"id":206,"title":207,"source":208,"logo":43,"time":139},1277752,"FDA Advisory Committee Convenes on Peptides This Week, Understanding What Reclassification Mean","https://www.einpresswire.com/article/927754517/fda-advisory-committee-convenes-on-peptides-this-week-understanding-what-reclassification-mean",{"id":210,"title":211,"source":212,"logo":19,"time":94},1277718,"The Great Peptide Cash Grab Has Begun","https://www.wired.com/story/fda-peptide-decision-telehealth-companies-cashing-in",{"id":214,"title":215,"source":216,"logo":5,"time":107},1277719,"FDA raised conflict of interest concerns ahead of new peptide panel","https://www.washingtonpost.com/health/2026/07/17/fda-raised-conflict-interest-concerns-ahead-new-peptide-panel",{"id":218,"title":219,"source":220,"logo":24,"time":148},1277757,"What Are Peptides? The Viral Health Trend, Explained","https://www.mentalfloss.com/live-smarter/what-are-peptides",{"id":222,"title":223,"source":224,"logo":58,"time":107},1277758,"The Next Wave Of Peptides Could Be Here; What Does It Mean For Lilly, Novo?","https://www.investors.com/news/technology/eli-lilly-novo-nordisk-peptides-fda-cpac-meeting",{"id":226,"title":227,"source":228,"logo":28,"time":94},1277759,"FDA Adds More Peptide Panel Experts After Conflict Criticism","https://news.bloomberglaw.com/health-law-and-business/fda-adds-more-peptide-panel-experts-after-conflict-criticism",{"id":230,"title":231,"source":232,"logo":20,"time":94},1277720,"FDA’s Review Of Peptides Signals A Growing Public Health Challenge—Separating Science From Hype","https://www.forbes.com/sites/omerawan/2026/07/21/fdas-review-of-peptides-signals-a-growing-public-health-challenge--separating-science-from-hype",{"id":234,"title":235,"source":236,"logo":46,"time":94},1277764,"Trevor Kruder, CEO of Paramount Health Rx and Alpha BioMed Industries, Available for Media Commentary on FDA Compounding Advisory Committee Meeting","https://sg.finance.yahoo.com/news/trevor-kruder-ceo-paramount-health-100300471.html",{"id":238,"title":239,"source":240,"logo":21,"time":139},1277721,"How peptides became longevity medicine’s hottest frontier","https://www.ft.com/content/f0f66461-269c-42ab-876e-b1ec9dfe3cb9",{"id":242,"title":243,"source":244,"logo":16,"time":112},1277765,"Everyone's talking about peptides, but are they better than protein?","https://www.indiatvnews.com/lifestyle/news/the-peptide-boom-are-peptides-the-new-protein-wellness-trend-2026-07-14-1048202",{"id":246,"title":247,"source":248,"logo":45,"time":94},1277722,"Notes from a peptide meetup","https://endpoints.news/notes-from-a-peptide-meetup",{"id":250,"title":194,"source":251,"logo":51,"time":148},1277766,"https://shopping.yahoo.com/beauty/skincare/articles/every-derm-know-tells-put-142133495.html",{"id":253,"title":254,"source":255,"logo":39,"time":139},1277723,"What to know about the seven peptides an FDA advisory panel is set to review this week","https://www.nbcnews.com/health/health-news/seven-peptides-deregulation-fda-review-what-know-rcna588022",{"id":257,"title":207,"source":258,"logo":5,"time":139},1277767,"https://www.einnews.com/pr_news/927754517/fda-advisory-committee-convenes-on-peptides-this-week-understanding-what-reclassification-mean",{"id":260,"title":261,"source":262,"logo":37,"time":94},1277760,"83% of peptide-aware Americans want the FDA to make peptides more accessible","https://www.aol.com/articles/83-peptide-aware-americans-want-190006000.html",{"id":264,"title":167,"source":265,"logo":41,"time":94},1277761,"https://www.aol.com/articles/americans-want-fda-end-peptide-174900000.html",{"id":267,"title":167,"source":268,"logo":22,"time":94},1277762,"https://www.streetinsider.com/PRNewswire/Americans+Want+FDA+to+End+Peptide+Roulette%2C+New+National+Poll+Finds/26794965.html",{"id":270,"title":271,"source":272,"logo":29,"time":94},1277763,"FDA’s Review Of Peptides Signals A Growing Public Health Challenge— Separating Science From Hype","https://uk.news.yahoo.com/fda-review-peptides-signals-growing-122256642.html",{"id":274,"title":275,"source":276,"logo":47,"time":94},1277728,"Why Some Scientists Are Worried About the Peptide Boom","https://medshadow.org/drug-updates-recalls/drug-safety/fda-unapproved-peptides-safety",{"id":278,"title":151,"source":279,"logo":31,"time":94},1277729,"https://news.bloomberglaw.com/product-liability-and-toxics-law/fda-panel-to-revisit-biden-peptide-ban-as-it-weighs-looser-rules",{"id":281,"title":282,"source":283,"logo":62,"time":139},1277724,"The FDA’s peptide vote could create telehealth’s next multibillion-dollar market","https://fortune.com/2026/07/20/the-fda-peptide-vote-could-create-telehealths-next-multibillion-dollar-market-telehealth-hims-ro-glp1-ozempic-injectables",{"id":285,"title":286,"source":287,"logo":48,"time":107},1277768,"What The Peptide Boom Reveals About Modern Leadership","https://www.forbes.com/sites/julianhayesii/2026/07/17/what-the-peptide-boom-reveals-about-modern-leadership",{"id":289,"title":290,"source":291,"logo":33,"time":94},1277725,"Peptides: FDA May Ease Restrictions Despite Concerns From Experts","https://www.healthline.com/health-news/compounded-peptides-eased-restrictions-fda",{"id":293,"title":128,"source":294,"logo":26,"time":139},1277769,"https://www.aol.com/articles/people-swear-peptide-stacking-actually-135249000.html",{"id":296,"title":297,"source":298,"logo":5,"time":94},1277726,"10 questions to ask your doctor about peptides","https://www.aamc.org/news/10-questions-ask-your-doctor-about-peptides",{"id":300,"title":301,"source":302,"logo":59,"time":94},1277727,"UPDATE: Americans Want FDA to End Peptide Roulette, New National Poll Finds","https://finance.yahoo.com/healthcare/articles/americans-want-fda-end-peptide-212200640.html",{"id":304,"title":305,"source":306,"logo":25,"time":307},1277770,"Big Pharma's Peptide Fight? Partnership for Safe Medicines Urges FDA to Reject Seven Compounded Peptides","https://www.trialsitenews.com/a/big-pharmas-peptide-fight-partnership-for-safe-medicines-urges-fda-to-reject-seven-compounded-peptides-daa0d956","12D AGO",{"id":309,"title":310,"source":311,"logo":30,"time":312},1277731,"Survey Shows Peptide Misinformation, Misuse Rising in US","https://www.hcplive.com/view/survey-shows-peptide-misinformation-misuse-rising-in-us","4D AGO",{"id":314,"title":315,"source":316,"logo":10,"time":312},1277732,"Supplement Industry Plants Longtime Use Flag As US Looks At Expanding Peptide Bulk Drugs List","https://insights.citeline.com/hbw-insight/wellness/policy-and-regulation/regulation/supplement-industry-plants-longtime-use-flag-as-us-looks-at-expanding-peptide-bulk-drugs-list-LFXWNXBFQBBCTA7JESNDO6ZASU",{"id":318,"title":319,"source":320,"logo":34,"time":139},1277733,"The peptide craze","https://theweek.com/health/the-peptide-craze",{"id":322,"title":323,"source":324,"logo":14,"time":312},1277734,"Peptides promise more than weight loss. Researchers are still deciding if they deliver.","https://www.nola.com/entertainment_life/louisiana_health/peptides-promise-more-than-weight-loss-researchers-are-still-deciding-if-they-deliver/article_b29c6d06-0fb3-485c-a3a4-0d589c7ff486.html",{"id":326,"title":105,"source":327,"logo":5,"time":107},1277771,"https://aijourn.com/apha-urges-fda-to-put-patient-safety-first-in-review-of-peptide-substances",{"id":329,"title":330,"source":331,"logo":15,"time":139},1277730,"Peptide deals flow amid manufacturing land grab","https://www.axios.com/pro/biotech-deals/2026/07/20/peptide-dealmaking-polypeptide-samsung",{"id":333,"title":261,"source":334,"logo":27,"time":94},1277739,"https://www.caledonianrecord.com/83-of-peptide-aware-americans-want-the-fda-to-make-peptides-more-accessible/article_cfa686f6-8452-548b-805c-7bd65bb56950.html",{"id":336,"title":337,"source":338,"logo":23,"time":112},1277735,"Peptides for injury recovery: medical miracle or medical risk?","https://www.foxcarolina.com/2026/07/14/peptides-injury-recovery-medical-miracle-or-medical-risk",{"id":340,"title":341,"source":342,"logo":49,"time":148},1277736,"East Texas expert warns of new peptide drugs trending on social media","https://www.kltv.com/2026/07/17/east-texas-expert-warns-new-peptide-drugs-trending-social-media",{"id":344,"title":345,"source":346,"logo":61,"time":94},1277737,"'Gusto mo bang pumayat?': Doctor tells public to be cautious about peptide craze","https://www.abs-cbn.com/lifestyle/health-beauty-fashion/2026/7/21/-gusto-mo-bang-pumayat-doctor-tells-public-to-be-cautious-about-peptide-craze-0947",{"id":348,"title":349,"source":350,"logo":11,"time":125},1277738,"Peptides trending on social media: Experts urge caution before buying into the hype","https://www.nbcdfw.com/news/health/peptides-trending-social-media-experts/4049894","#116fc8ff","#116fc84d",1784903477835]